secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001104659-25-104427
Event type: m_and_a
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

NWBO closes Advent BioServices acquisition; pays £1.4M + AP over 2 years; 19M securities revert
--------------------------------------------------------------------------------

- Acquisition of Advent BioServices closed; Advent becomes wholly owned subsidiary.
- No new shares issued; 13.5M shares and 5.5M options previously issued to Advent revert to NWBO.
- Consideration: £1.4 million plus net accounts payable, paid in installments over two years starting 90 days post-closing.
- Installment payments may accelerate upon regulatory approval of DCVax-L; NWBO receives fixed assets, cryostorage, and IP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465925104427/0001104659-25-104427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465925104427/tm2529815d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-104427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer